SOL PHARMACEUTICALS LTD

Business Overview

• Sol Pharmaceuticals Ltd is a Hyderabad-based public limited company, CIN L24239TG1983PLC004355, incorporated in 1983, operating in manufacturing of chemical products and pharmaceuticals / drug formulation and development (NIC 24239).
• Legal-case history (Indian Kanoon) shows historical operations spanning excise/customs matters in Bidar and Chennai, indicating past manufacturing units beyond Hyderabad.
• Contact email on record: solpharma@rediffmail.com — no active/functioning corporate website could be located, domain guess solpharma.in does not resolve, consistent with a long-dormant listed entity.
• Source: Tofler, TheCompanyCheck, Indian Kanoon.

Sector & Classification

Manufacturing of Pharmaceuticals / Drug formulation & development (NIC 24239) — Tofler, TheCompanyCheck agree

Directors & Key Management

GST Registrations

not obtained — could not confirm any GSTIN for this entity via KnowYourGST, MastersIndia, or FindGST (search/dynamic pages returned no static data through fetch; direct GSTIN was not discoverable without a working name-search). PAN also not obtained, which is a prerequisite for deriving/verifying GSTIN. Flagging as a gap rather than guessing (per entity-confusion rule).

Financials

• Not obtained (partial).
• Screener.in has a page for ticker "SOLPHARMA", BSE scrip 500393, but all P&L/balance-sheet fields are blank/unpopulated in Screener's database — explicit message "Shareholding pattern is currently not available for this company" and no annual report data loaded.
• Tofler's financial page confirms a FY March 2025 filing exists, percentage deltas visible: revenue -6.49%, EBITDA -6.6%, net profit +190.59%, net worth -7.96%, borrowings +47.15%, total assets +3.46% YoY, but absolute rupee figures are paywalled behind Tofler Pro and were not obtained.
• Last AGM: 30 Sep 2024
• Last balance sheet date: March 2025 (Tofler). No standalone-vs-consolidated distinction could be confirmed.

Loans & Charges

• 6 registered charges totaling ~₹108.4 crore, source: TheCompanyCheck, corroborated in substance by Tofler's charges reference.
• By holder: Girija Investments Pvt Ltd — 4 charges, ~₹108.3 cr total, ₹79.7 cr created 24 Aug 2017; ₹8.6 cr created 06 Apr 2009; ₹10.0 cr created 20 Dec 2007; ₹10.0 cr created 20 Dec 2007.
• Corporation Bank — 2 charges, ~₹0.1 cr total, created 09 Nov 1995 and 05 Sep 1995.
• Satisfaction/open status per-charge not confirmed — treat as "open/registered" per source language, not verified against MCA filing index directly, MCA itself is a blocked source per instructions.

Related Parties

• Not obtained — no subsidiaries, group companies, or related-party names surfaced on Tofler/TheCompanyCheck free pages.
• Girija Investments Pvt Ltd is the dominant secured lender, ₹108.3 cr across 4 charges, and may be a promoter-linked/related financing entity, but no source confirms a related-party relationship — flagging as a possible link requiring separate verification, not stated as fact.

Legal & Compliance

• Multiple historical litigations found on Indian Kanoon: (1) Sol Pharmaceuticals Ltd vs Income Tax Officer, ITAT Hyderabad, 21 Nov 2001 [2002]83ITD72 (HYD)
• (2) Sol Pharmaceuticals Ltd vs Commissioner of Customs, Chennai, CEGAT Tamil Nadu, 25 Sep 2001
• (3) M/S Sol Pharmaceuticals Ltd, Bidar vs Commissioner of Central Excise, CEGAT Bangalore, 27 Sep 2001
• (4) Sol Pharmaceuticals Ltd vs Dr. Jaswant Dilipsing Patil, Bombay HC (Aurangabad), Crl. WP 378/2004, 13 Jun 2013
• (5) Sol Pharmaceuticals Ltd vs State of AP/Telangana, Telangana HC, 8 Sep 2025
• (6) Sol Pharmaceutical Ltd vs State of Karnataka & Ors, Karnataka HC, WP 203349/2024, 28 Nov 2024
• (7) Sol Pharmaceuticals Ltd vs Registrar of Companies & Anr, Andhra HC (pre-Telangana), 8 Apr 2002
• (8) Sol Pharmaceutical Ltd vs BSNL, Telangana HC, 6 Jan 2020
• (9) Sol Pharmaceuticals Ltd vs Chairman & MD, IDBI & Ors, Delhi HC, WP (C) 10384/2015, 13 Feb 2023.
• Pattern of recurring litigation, tax, excise, RoC, banking/IDBI, over decades is consistent with the "Active Non-Compliant" flag and financial distress signals, high secured charges, blank financials.

Competitive Landscape

• Given the ambiguity between "listed BSE micro-cap" and "MCA-classified unlisted," and lack of confirmed current revenue scale, named peers are offered directionally only, same NIC/pharma-formulation space, small-to-mid Indian formulation manufacturers: Unichem Laboratories, mid-cap, listed, several hundred crore revenue, Indoco Remedies, mid-cap, listed, ~₹1,600 cr revenue, FDC Ltd, mid-cap, listed, ~₹1,500 cr revenue, Suven Pharmaceuticals, listed, larger scale, Sequent Scientific, listed, formulation/API, Aarti Drugs, listed, API/formulation.
• Sol Pharmaceuticals itself appears to be at the smallest/dormant end of this set, no current revenue confirmed, — competitor scale tags are for the broader category, not a like-for-like match
• Not obtained: any confirmed direct competitor from an industry source.

Frequently Asked Questions

Sources

Tofler (tofler.in/sol-pharmaceuticals-limited/company/L24239TG1983PLC004355 — identity, capital, director, financials-locked, charges reference); TheCompanyCheck (thecompanycheck.com/company/sol-pharmaceuticals-limited/L24239TG1983PLC004355 — identity, capital, charges detail, compliance status); Screener.in (screener.in/company/SOLPHARMA — BSE scrip 500393/ticker SOLPHR reference, empty financials/shareholding); Indian Kanoon (indiankanoon.org — 9 litigation records 2001-2025). Attempted but returned no usable data: Falconebiz (homepage only), BSE India direct pages (404/no data — likely JS-rendered), KnowYourGST/MastersIndia/FindGST (GSTIN search — no static results via fetch), Moneycontrol (fetch blocked), Groww/Equitymaster/Tickertape (404/no data), solpharma.in (does not resolve). WebSearch tool was unavailable for this session (budget exhausted at 200/200 calls) — all research after the initial validation gate relied on direct WebFetch to known-reliable domains rather than search-driven discovery.